
Dr. Shikhar Kumar
Consultant Medical Oncologist
Medical Oncologist
134 verified reviews
134
Recent Consultations
About Dr. Shikhar Kumar
Dr. Shikhar Kumar is a Consultant Medical Oncologist at Yashoda Hospitals, Hyderabad, with over 13 years of specialised experience in comprehensive cancer care. He holds an MBBS from Kamineni Institute of Medical Sciences, an MD in Radiation Oncology from PGIMER Chandigarh, and a prestigious DM in Medical Oncology from Tata Memorial Hospital, Mumbai. His distinction as a European Certified Medical Oncologist (ECMO) reflects his commitment to adhering to international standards in oncology practice.
Dr. Kumar's clinical expertise spans the full spectrum of hematological and solid organ malignancies. He has extensive experience managing acute leukemias, lymphomas, myeloma, and chronic myeloid and lymphoid leukemias, as well as breast, lung, prostate, ovarian, head and neck, testicular, kidney, gastric, and colorectal cancers. His multidisciplinary training enables him to design evidence-based, personalised treatment strategies that integrate chemotherapy, immunotherapy, targeted therapy, and hormone-based interventions tailored to each patient's tumour biology and clinical circumstances.
Dr. Kumar regularly treats international patients from the Gulf region, Africa, and neighbouring South Asian countries who seek oncology care at Yashoda Hospitals. He is fluent in English, Hindi, and Telugu, facilitating seamless communication with a diverse patient population. His patient-centred approach emphasises clear prognostic discussion, shared decision-making, and supportive care throughout the cancer journey.
Yashoda Hospitals in Hyderabad is a leading tertiary cancer centre equipped with advanced chemotherapy infusion units, molecular diagnostic facilities, and multidisciplinary tumour boards. The hospital maintains rigorous quality standards and supports international patients with dedicated coordination, documentation translation, and follow-up care. Hyderabad's accessibility as a major healthcare hub, combined with Yashoda's infrastructure and Dr. Kumar's extensive training, makes it an attractive destination for patients seeking high-quality oncology care in a cost-effective setting.
Conditions Treated by Dr. Shikhar Kumar
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Ovarian Cancer
- Head and Neck Cancer
- Hematological Malignancies
- Acute Leukemias
- Lymphomas
- Gastric Cancer
- Colorectal Cancer
- Testicular Cancer
- Renal Cell Carcinoma
Areas of Interest
- Chemotherapy for Cancer
- Cancer Immunotherapy
- Targeted Therapy for Cancer
- Hormone Therapy for Breast Cancer
- Hormone Therapy for Prostate Cancer
- Hematological Malignancies
- Acute Leukemias
- Lymphomas
- Breast Cancer Treatment
- Lung Cancer Treatment
- Head and Neck Cancer Treatment
- Ovarian Cancer Treatment
Qualifications
- MBBS — Kamineni Institute of Medical Sciences, 2012
- MD — Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 2016
- DNB — , 2016
- DM — Tata Memorial Hospital, Mumbai, 2020
- ECMO — , 2021
Work Experience
- Consultant Medical Oncologist, Yashoda Hospitals, Hyderabad — Present
- Assistant Professor (Ad-Hoc), Tata Memorial Hospital, Mumbai — 2020–2021
- Senior Residency in Radiation Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi — 2016–2017
- Rotating Internship, Gandhi Medical College, Hyderabad — 2012–2013
Certifications (5)
MBBS
Kamineni Institute of Medical Sciences — 2012
MD in Radiation Oncology
Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh — 2016
DNB in Radiation Oncology
National Board of Examinations — 2016
DM in Medical Oncology
Tata Memorial Hospital, Mumbai — 2020
European Certified Medical Oncologist (ECMO)
European Society for Medical Oncology — 2021
Memberships (0)
Research Papers & Publications (5)
Role of stereotactic body radiation therapy in liver metastasis: A pilot study from a tertiary cancer institute in India
Journal of Cancer Research and Therapeutics — 2019
Advances in pharmacotherapy for head and neck cancer
Expert Opinion on Pharmacotherapy — 2021
Factors Influencing Compliance to Radical Treatment of Middle Thoracic Esophageal Cancer
Indian Journal of Palliative Care — 2016
Fractionated Palliative Pelvic Radiotherapy in Recurrent/Refractory Epithelial Ovarian Cancers
Journal of Obstetric and Gynaecology India — 2017
Molecular targets in urinary bladder cancer
International Journal of Molecular and Immuno Oncology — 2022
Procedures
Frequently Asked Questions
International patients can book a consultation through Gaf Healthcare's telemedicine platform via video call, WhatsApp, or email. Patients need to submit their medical reports, imaging scans, and pathology findings, which Dr. Kumar will review before the consultation. Gaf Healthcare coordinates all scheduling and documentation, making the process seamless for patients across the globe.
